scispace - formally typeset
K

Kevin Bouiller

Researcher at Centre national de la recherche scientifique

Publications -  108
Citations -  1852

Kevin Bouiller is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 74 publications receiving 742 citations. Previous affiliations of Kevin Bouiller include University of Franche-Comté & University of Burgundy.

Papers
More filters
Journal ArticleDOI

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

Florence Ader, +163 more
TL;DR: The DisCoVeRy trial as mentioned in this paper evaluated the clinical efficacy of remdesivir plus standard care compared with standard of care alone in patients admitted to hospital with COVID-19, with indication of oxygen or ventilator support.
Journal ArticleDOI

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

Jérôme Avouac, +462 more
TL;DR: In this article, the authors investigated whether treatment with rituximab is associated with severe COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases.
Journal ArticleDOI

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.

TL;DR: Elevated D-dimers (>2590 ng·mL−1) and absence of anticoagulant therapy predict PE in hospitalised COVID-19 patients with clinical signs of severity, and suggest wider use of D-dimer guided CTPA to screen for PE in acutely ill hospitalised patients with CO VID-19.